Jadelle 2 X 75 mg Implants
PDF Leaflet Revision Date: 23 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Contraception.
Dosage (summary)
Two implants inserted sub-dermally, effective for up to 5 years.
Special Populations
- Paediatric population
- Women over 60 kg
Pregnancy & Breastfeeding
Remove implants if pregnancy occurs; do not use during breastfeeding until 6 weeks postpartum.
Key Drug Interactions
- Phenytoin
- Carbamazepine
- Rifampicin
- St. John's wort
Contraindications
- Hypersensitivity to levonorgestrel
- Undiagnosed abnormal vaginal bleeding
- Acute liver disease
- History of thromboembolic disease
Common side effects
- Headache
- Nausea
- Dizziness
- Weight gain
- Irregular menstrual bleeding
Counselling Points
- Keep insertion area dry for 3 days
- Monitor for mood changes
- Use additional contraception if switching from other hormonal methods
Serious warnings
- Efficacy decreases after 4 years
- Risk of thromboembolic events
- Mood changes and depression
Important Disclaimer
The Jadelle 2 X 75 mg Implants professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
